Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-25-001484
Filing Date
2025-02-03
Accepted
2025-02-03 20:12:17
Documents
1
Period of Report
2025-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp224420_4-shah.html 4  
1 FORM 4 dp224420_4-shah.xml 4 5254
  Complete submission text file 0000950103-25-001484.txt   6779
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Issuer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PRECIGEN, INC. 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address
Shah Rutul R (Reporting) CIK: 0001947221 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36042 | Film No.: 25584524